ArticleFrontiers in immunology2024

Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia-causing serogroup B and E strains of

Jamie E Fegan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.